The Cancer Drug Response Mutation dataset is a collection of features that are associated with the response of cancer cells to different drugs. This dataset is characterized by a range of genetic mutations that are present in the tumor suppressor genes TNFRSF14 and PRDM16.

The features of this dataset include mutations in the TNFRSF14 gene, which is a tumor suppressor gene that plays a critical role in regulating cell death and inflammation. The mutations in this gene are associated with a range of different responses to cancer drugs, including resistance to chemotherapy and targeted therapies.

In addition to the TNFRSF14 gene, the dataset also includes features related to the PRDM16 gene, which is another tumor suppressor gene that is involved in regulating cell growth and differentiation. The mutations in this gene are also associated with different responses to cancer drugs, including sensitivity to chemotherapy and targeted therapies.

Overall, the Cancer Drug Response Mutation dataset is a valuable resource for researchers who are seeking to understand the genetic mechanisms that underlie the response of cancer cells to different drugs. By analyzing the features of this dataset, researchers may be able to identify new biomarkers for predicting the response of cancer cells to different treatments, and develop more effective personalized therapies for cancer patients.

Keywords: Cancer, Drug Response, Mutation, TNFRSF14, PRDM16, Tumor Suppressor Genes, Personalized Therapies.